Close

Adaptimmune Therapeutics (ADAP) Announces Lift of FDA Partial Clinical Hold on NY‑ESO SPEAR in MRCLS

Go back to Adaptimmune Therapeutics (ADAP) Announces Lift of FDA Partial Clinical Hold on NY‑ESO SPEAR in MRCLS
(NASDAQ: ADAP) Delayed: 1.06 --0 (-0%)
Previous Close $1.06    52 Week High $12.85 
Open $1.06    52 Week Low $3.76 
Day High $1.06    P/E N/A 
Day Low $1.06    EPS $0.00 
Volume 99